PSMA expression in the neovasculature of non-prostatic tumors, such as renal cell carcinoma, hepatocellular carcinoma, or glioblastoma, can produce misleading uptake unrelated to prostate cancer [12]. The gene discussed is FOLH1; the disease is prostate cancer.